Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Frontiers in Medicine|June 26, 2024
Tezepelumab improved chronic eosinophilic pneumonia in severe asthma patients with liver cirrhosisMizuki Inaba, Yasuo Shimizu, Yusuke Nakamura, et al.
Kyobu Geka. the Japanese Journal of Thoracic Surgery|July 17, 2025
[Bronchoscopic Lung Volume Reduction for Severe Chronic Obstructive Lung Disease]Takahiro Nakajima, Takashi Inoue, Hiroaki Okutomi, et al.
Thoracic Cancer|March 23, 2022
Carboplatin plus nab-paclitaxel for recurrent small cell lung cancer: A phase II studyNaoya Ikeda, Ryo Arai, Sayo Soda, et al.
Journal of Clinical Medicine|September 9, 2023
Changes in Peripheral Blood Eosinophil Counts and Risk of Eosinophilic Granulomatosis with Polyangiitis Onset after Initiation of Dupilumab Administration in Adult Patients with AsthmaYoshitomo Kushima, Yasuo Shimizu, Hiromi Hoshi, et al.
Respirology Case Reports|May 21, 2026
Bronchoscopic Direct Drainage of a Treatment-Resistant Lung Abscess via Endoscopic Balloon Dilation in a High-Risk PatientNana Yazawa, Yusuke Nakamura, Akihiro Takemasa, et al.
Respiratory Investigation|September 29, 2023
Transcutaneous gas monitoring is a useful tool to detect respiratory depression during bronchoscopy performed under propofol sedationNana Yazawa, Yusuke Nakamura, Akihiro Takemasa, et al.
Journal of Clinical Biochemistry and Nutrition|October 12, 2020
Auto-antibody evaluation in idiopathic interstitial pneumonia and worse survival of patients with Ro52/TRIM21auto-antibodyHiroko Morita, Yasuo Shimizu, Yusuke Nakamura, et al.
Frontiers in Allergy|April 1, 2025
Real-life effectiveness of once-daily single-inhaler triple therapy (FF-UMEC-VI) after switching from dual therapy (ICS-LABA) in patients with symptomatic asthma: trelegy ellipta for real asthma control studyYoshitomo Kushima, Yasuo Shimizu, Ryo Arai, et al.
Frontiers in Allergy|October 9, 2025
Correction: Real-life effectiveness of once-daily single-inhaler triple therapy (FF-UMEC-VI) after switching from dual therapy (ICS-LABA) in patients with symptomatic asthma: trelegy ellipta for real asthma control studyYoshitomo Kushima, Yasuo Shimizu, Ryo Arai, et al.
Pageof 1